Retraction statement: National database study on the use of long-acting antipsychotic injections and hospital readmission proportions in patients with schizophrenia in Japan

撤稿声明:日本国家数据库关于长效抗精神病药物注射剂使用情况及精神分裂症患者再入院率的研究

阅读:1

Abstract

Usuki M, Kamiura Y, Okubo R, Yamanouchi Y. National database study on the use of long-acting antipsychotic injections and hospital readmission proportions in patients with schizophrenia in Japan. Psychiatry Clin. Neurosci. 2020; 74: 211-217. https://doi.org/10.1111/pcn.12970 The above article from Psychiatry and Clinical Neurosciences, published online on 3 February 2020 in Wiley Online Library (www.onlinelibrary.wiley.com), and in Volume 74, pp. 211-217, has been retracted by agreement between the authors, the Editors-in-Chief, Shigenobu Kanba and Tadafumi Kato, and John Wiley & Sons Australia Ltd. The retraction has been issued because the Ministry of Health, Labour and Welfare (MHLW) announced that the authors violated the guidelines on the use of the data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB Japan) in the article. REFERENCE: Usuki M, Kamiura Y, Okubo R, Yamanouchi Y. National database study on the use of long-acting antipsychotic injections and hospital readmission proportions in patients with schizophrenia in Japan. Psychiatry Clin. Neurosci. 2020; 74: 211-217. https://doi.org/10.1111/pcn.12970.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。